Skip to main content

Table 3 Adjusted hazard ratios for incident atrial fibrillation per one standard deviation increase in adhesion pathway protein

From: Adhesion pathway proteins and risk of atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis

 

Pooled sample

Model 1a

Model 2b

Hazard ratio

(95% CI)

P valuec

Hazard ratio

(95% CI)

P valuec

Race/Ethnicity interaction P valuec,d

Exam 1

HGFe

1.18 (1.10 -1.26)

 < 0.0001

1.10 (1.02–1.18)

0.009

0.28

Exam 2

MMP-1

1.02 (0.91–1.15)

0.72

1.02 (0.90–1.15)

0.76

0.36

MMP-2

1.25 (1.10–1.42)

 < 0.001

1.27 (1.11–1.45)

 < 0.001

0.14

TIMP-2

1.27 (1.11–1.44)

 < 0.001

1.28 (1.12–1.46)

 < 0.001

0.89

ICAM-1

1.11 (0.97–1.28)

0.13

1.09 (0.95–1.26)

0.23

0.51

VCAM-1

1.32 (1.17–1.50)

 < 0.001

1.32 (1.16–1.5)

 < 0.001

0.69

P-selectin

1.09 (0.86–1.40)

0.48

1.06 (0.83–1.37)

0.63

0.18

L-selectin

1.01 (0.88–1.15)

0.93

1.04 (0.90–1.20)

0.61

0.92

RANTES

1.02 (0.90–1.14)

0.8

1.03 (0.91–1.16)

0.68

0.80

E-cadherin

1.01 (0.88–1.15)

0.94

0.99 (0.85–1.14)

0.86

0.59

TGF-β1

1.00 (0.89–1.13)

0.97

0.99 (0.88–1.13)

0.97

0.79

CCL-21

1.20 (1.05–1.37)

0.008

1.17 (1.02–1.35)

0.025

0.76

SDF-1α

1.14 (1.00–1.30)

0.046

1.11 (0.97–1.27)

0.12

0.83

SLPI

1.22 (1.08–1.38)

0.001

1.22 (1.07–1.38)

0.003

0.02

IL-2 sR

1.22 (1.08–1.37)

0.001

1.20 (1.06–1.36)

0.004

0.22

  1. CCL-21 Chemokine ligand 21, HGF hepatocyte growth factor, ICAM-1 intercellular adhesion molecule 1, IL-2 sR interleukin 2 soluble receptor, MMP-1 matrix metalloproteinase 1, MMP-2 matrix metalloproteinase 2, RANTES regulated on activation normal T cell expressed and secreted, SDF-1α stromal-derived factor 1α, SLPI secretory leukocyte protease inhibitor, TGF-β1 transforming growth factor β1, TIMP-2 tissue inhibitor of metalloproteinase 2, VCAM-1 vascular cell adhesion molecule 1
  2. aAdjusted for age, sex, and race/ethnicity. Proteins were not transformed for the analyses. Hazard ratios presented are for a 1 standard deviation unit change for each protein
  3. bAdjusted for model 1 + height, body mass index, systolic blood pressure, antihypertension therapy, diabetes status, current smoker, current alcohol use, and total and HDL cholesterol
  4. cThreshold for statistical significance P < 0.0033 (0.05/15)
  5. dThe race/ethnicity interaction term is not included in the final model. Stratified results are presented in Additional file 1: Table S3
  6. eThere were 74,960 person-years of follow up for the Exam 1 HGF analysis (average: 11.2 years), 851 incident cases of AF were identified (186 African Americans, 105 Chinese Americans, 151 Hispanic Americans, and 409 non-Hispanic white Americans)